AML M4
AML M4 Eo with inv 16) or t 16;16)
A pediatric acute myeloid leukemia involving both myeloid and monocytoid precursors. At least 20% of non-erythroid cells are of monocytic origin.
An acute leukemia characterized by the proliferation of both neutrophil and monocyte precursors. Patients typically present with anemia, thrombocytopenia, fever and fatigue. This type of leukemia frequently responds to aggressive therapy. who, 2001)
C92.5 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
The 2023 edition of ICD-10-CM C92.5 became effective on October 1, 2022.
This is the American ICD-10-CM version of C92.5 – other international versions of ICD-10 C92.5 may differ.